Polymeric microneedles: advances in drug delivery
DOI:
https://doi.org/10.34119/bjhrv8n3-159Keywords:
microneedles, transdermal drug delivery, stratum corneumAbstract
Polymeric microneedles (MNs) represent a promising technology for transdermal drug delivery, overcoming the limitations of the stratum corneum and enabling the delivery of large or hydrophilic molecules, such as vaccines, insulin, and phytocompounds. Despite advancements, challenges related to scalability, biocompatibility, and formulation optimization remain. This study investigated the role of polymeric MNs as an effective strategy for drug delivery, assessing their applicability, efficiency, and advantages compared to traditional methods. A systematic review was conducted following PRISMA guidelines. The search was performed in the ScienceDirect and PubMed databases, covering articles published between 2013 and 2023. Eligible studies included data on applications, drug types, and MN presentation forms. Data analysis was carried out using StArt software, and drug transdermal permeability was evaluated with tools like PubChem and PreADMET. In this context, 25 studies met the inclusion criteria. MNs demonstrated high versatility in delivering drugs for infectious, inflammatory, oncological, and chronic diseases. Biodegradable and water-soluble polymers were widely used, ensuring controlled and sustained release. The technology showed superior efficacy in molecule permeation, increased treatment adherence, and lower incidence of side effects. Polymeric MNs offer innovative solutions for drug delivery, standing out for their versatility and efficiency. However, limitations such as payload capacity, biocompatibility, and production costs require further investigation. Academic-industrial partnerships and advancements in material science are essential for enabling large-scale clinical applications.
References
AACHLA, T. et al. The Study of Various Approaches for the Transdermal Patches Possess Therapeutic Potential. International Journal For Multidisciplinary Research, v. 6, n. 2, p. 17150, 21 abr. 2024.
ABDUL AZIZ, A. F. et al. A Review on the Mechanisms, Applications, and Clinical Trials of Advanced Technologies in the Transdermal Drug Delivery System. Current Pharmaceutical Biotechnology, v. 25, 22 ago. 2024.
ABHISHEK, A. et al. A Review Article on Transdermal Drug Delivery System. Asian Journal of Pharmacy and Technology, p. 173–178, 27 maio 2024.
AHMAD, A. L.; YUSUF, N. M.; OOI, B. S. Preparation and modification of poly (vinyl) alcohol membrane: Effect of crosslinking time towards its morphology. Desalination, v. 287, p. 35–40, fev. 2012.
AJAYKUMAR, C. Overview on the Side Effects of Doxorubicin. Em: ARNOUK, H.; ABDUL RASOOL HASSAN, B. (Eds.). Advances in Precision Medicine Oncology. [s.l.] IntechOpen, 2021.
AL-BADRY, A. S.; AL-MAYAHY, M. H.; SCURR, D. J. Enhanced Transdermal Delivery of Acyclovir via Hydrogel Microneedle Arrays. Journal of Pharmaceutical Sciences, v. 112, n. 4, p. 1011–1019, 1 abr. 2023.
ALDAWOOD, F. K. et al. 3D Printing of Biodegradable Polymeric Microneedles for Transdermal Drug Delivery Applications. Pharmaceutics, v. 16, n. 2, p. 237, 6 fev. 2024.
ALHAQ, R.; INDAWATI, E. Hubungan Dukungan Keluarga dengan Kepatuhan Minum Obat pada Pasien Tuberculosis Paru. Malahayati Nursing Journal, v. 6, n. 11, p. 4446–4454, 1 nov. 2024.
ALIMARDANI, V. et al. In-situ nanomicelle forming microneedles of poly NIPAAm-b-poly glutamic acid for trans-scleral delivery of dexamethasone. Journal of Industrial and Engineering Chemistry, v. 119, p. 485–498, mar. 2023.
ANANDA, P. W. R. et al. Combination of transdermal patches and solid microneedles for improved transdermal delivery of primaquine. International Journal of Pharmaceutics, v. 609, p. 121204, nov. 2021.
ANJANI, Q. K. et al. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs. European Journal of Pharmaceutics and Biopharmaceutics, v. 158, p. 294–312, jan. 2021.
AROCHE, A. F.; NISSAN, H. E.; DANIELE, M. A. Hydrogel‐Forming Microneedles and Applications in Interstitial Fluid Diagnostic Devices. Advanced Healthcare Materials, v. 14, n. 1, p. 2401782, jan. 2025.
BAHADUR, S. et al. Advances and Challenges of Microneedle Assisted Drug Delivery for Biomedicals Applications: A Review. Current Pharmaceutical Biotechnology, v. 26, 4 nov. 2024.
BAIRAGI, A.; JAIN, A.; K. SINGHAI, A. Dissolving Microneedles Drug Delivery System: A Comprehensive Review. Research Journal of Pharmaceutical Dosage Forms and Technology, p. 268–274, 7 ago. 2024.
BALA, M. et al. A Review: Microneedle Drug Delivery. Asian Journal of Research in Pharmaceutical Sciences, p. 236–242, 19 set. 2024.
BANKS, W. A. From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery. Nature Reviews Drug Discovery, v. 15, n. 4, p. 275–292, abr. 2016.
BHADALE, R. S.; LONDHE, V. Y. Inclusion complexed iloperidone loaded dissolving microneedles: Characterization, in-vitro study, and dermatopharmacokinetics. Journal of Drug Delivery Science and Technology, v. 68, p. 103063, fev. 2022.
BHATNAGAR, S. et al. Dissolvable microneedle patch containing doxorubicin and docetaxel is effective in 4T1 xenografted breast cancer mouse model. International Journal of Pharmaceutics, v. 556, p. 263–275, fev. 2019.
BHAVYA PATEL et al. Microneedle: Recent Advancements In Transdermal Drug Delivery System. Journal of Pharmaceutical Negative Results, p. 2078–2086, 12 nov. 2022.
CHEN, M.-H. et al. Integrating the microneedles with carboplatin to facilitate the therapeutic effect of radiotherapy for skin cancers. Biomaterials Advances, v. 141, p. 213113, out. 2022a.
CHEN, S. et al. Optimal scaling analysis of polymeric microneedle length and its effect on transdermal insulin delivery. Journal of Drug Delivery Science and Technology, v. 56, p. 101547, abr. 2020.
CHEN, Y. et al. Research progress on the application of microneedle transdermal drug delivery system in dermatology. Life Research, v. 5, n. 2, p. 14, 2022b.
CHRISTENSEN, M.; JOHANSEN, P.; HAU, C. Storage of Polyvinylpyrrolidone (PVP) in Tissues Following Long‐Term Treatment with a PVP‐Containing Vasopressin Preparation. Acta Medica Scandinavica, v. 204, n. 1–6, p. 295–298, 12 jan. 1978.
DALI, P.; SHENDE, P. Use of 3D applicator for intranasal microneedle arrays for combinational therapy in migraine. International Journal of Pharmaceutics, v. 635, p. 122714, mar. 2023.
DATTA, D. et al. Ocular delivery of cyclosporine A using dissolvable microneedle contact lens. Journal of Drug Delivery Science and Technology, v. 70, p. 103211, abr. 2022.
DEMIR, Y. K.; AKAN, Z.; KERIMOGLU, O. Sodium Alginate Microneedle Arrays Mediate the Transdermal Delivery of Bovine Serum Albumin. PLoS ONE, v. 8, n. 5, p. e63819, 10 maio 2013.
DONNELLY, R. F. et al. Hydrogel‐Forming and Dissolving Microneedles for Enhanced Delivery of Photosensitizers and Precursors. Photochemistry and Photobiology, v. 90, n. 3, p. 641–647, maio 2014.
DOUROUMIS, D. 3D Printing of Pharmaceutical and Medical Applications: a New Era. Pharmaceutical Research, v. 36, n. 3, p. 42, s11095- 019-2575– x, mar. 2019.
DU, G. et al. Determination of the mechanical properties of polymeric microneedles by micromanipulation. Journal of the Mechanical Behavior of Biomedical Materials, v. 117, p. 104384, maio 2021a.
DU, G. et al. Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment. Journal of Controlled Release, v. 336, p. 537–548, ago. 2021b.
ECONOMIDOU, S. N. et al. 3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery. Materials Science and Engineering: C, v. 102, p. 743–755, set. 2019.
FERNANDES, K. D. A. P.; FELIX, P. A. O. Persistent docetaxel-induced supravenous erythematous eruption. Anais Brasileiros de Dermatologia, v. 90, n. 5, p. 728–730, out. 2015.
FU, K.; KLIBANOV, A. M.; LANGER, R. Protein stability in controlled-release systems. Nature Biotechnology, v. 18, n. 1, p. 24–25, jan. 2000.
GALVÃO, T. F.; TIGUMAN, G. M. B.; SARKIS-ONOFRE, R. A declaração PRISMA 2020 em português: recomendações atualizadas para o relato de revisões sistemáticas. Epidemiologia e Serviços de Saúde, v. 31, n. 2, p. e2022364, 2022.
GILL, H. S. et al. Effect of Microneedle Design on Pain in Human Volunteers. The Clinical Journal of Pain, v. 24, n. 7, p. 585–594, set. 2008.
GOWDA, B. H. J. et al. Microneedles as an Emerging Platform for Transdermal Delivery of Phytochemicals. Molecular Pharmaceutics, v. 21, n. 12, p. 6007–6033, 2 dez. 2024.
HE, Y. T. et al. Hydroquinone cream-based polymer microneedle roller for the combined treatment of large-area chloasma. European Journal of Pharmaceutics and Biopharmaceutics, v. 185, p. 5–12, abr. 2023.
JIAO, J. et al. Microneedle Technology in Analgesic Therapy. Preprints, , 27 ago. 2024. Disponível em: <https://www.authorea.com/users/820805/articles/1219125-microneedle-technology-in-analgesic-therapy?commit=1fba9f6cad4e9dc2b4e1da8b0b46f6a852b61d41>. Acesso em: 4 jan. 2025
KARVE, T. et al. Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches. Advanced Drug Delivery Reviews, v. 210, p. 115326, jul. 2024.
KHARE, N.; SHENDE, P. Microneedle system: a modulated approach for penetration enhancement. Drug Development and Industrial Pharmacy, v. 47, n. 8, p. 1183–1192, 3 ago. 2021.
KUMAR SARELLA, P. N. et al. Microneedle Arrays: Advancements, Applications and Future Prospects in Pharmaceutical Delivery. Asian Journal of Pharmacy and Technology, p. 229–236, 19 set. 2024.
KUMAR, V. et al. Enhancing vaccine accessibility and efficacy through microneedle patches. Journal of Healthcare Quality Research, v. 39, n. 6, p. 343–345, 1 nov. 2024.
LI, W. et al. Core-shell microneedle patch for six-month controlled-release contraceptive delivery. Journal of Controlled Release, v. 347, p. 489–499, jul. 2022.
LIANG, L. et al. Improved imiquimod-induced psoriasis like dermatitis using microneedles in mice. European Journal of Pharmaceutics and Biopharmaceutics, v. 164, p. 20–27, jul. 2021.
LIU, M. et al. Smart drug delivery and responsive microneedles for wound healing. Materials Today Bio, v. 29, p. 101321, dez. 2024.
LIU, Y. et al. Biodegradable and dissolvable resveratrol nanocrystals non-silicon microneedles for transdermal drug delivery. Journal of Drug Delivery Science and Technology, v. 86, p. 104653, set. 2023.
LU, T.; YANG, J. The implication and advantages of small-molecule drug. Theoretical and Natural Science, v. 24, n. 1, p. 76–80, 20 dez. 2023.
LUO, Z. W. et al. Dissolvable microneedle particles for enhanced topical drug delivery. Journal of Drug Delivery Science and Technology, v. 91, p. 105209, jan. 2024.
MAHOMED, A.; HUKINS, D. W. L.; KUKUREKA, S. N. Swelling of medical grade silicones in liquids and calculation of their cross-link densities. Medical Engineering & Physics, v. 32, n. 4, p. 298–303, maio 2010.
MARKMAN, M. Management of toxicities associated with the administration of taxanes. Expert Opinion on Drug Safety, v. 2, n. 2, p. 141–146, mar. 2003.
MATADH, A. V. et al. Polymer coated polymeric microneedles for intravitreal delivery of dexamethasone. Experimental Eye Research, v. 231, p. 109467, jun. 2023.
MCCRUDDEN, M. T. C. et al. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. Journal of Controlled Release, v. 180, p. 71–80, abr. 2014.
MOHITE, P. et al. Hydrogel-Forming Microneedles in the Management of Dermal Disorders Through a Non-Invasive Process: A Review. Gels, v. 10, n. 11, p. 719, 7 nov. 2024.
MOHR, W.; ENDRES-KLEIN, R. Kommen um die Jahrtausendwende noch Polyvinylpyrrolidon-Ablagerungen in inneren Organen vor?: Beobachtungen an 3 Patientinnen aus der ehemaligen Union der Sozialistischen Sowjetrepubliken (UdSSR). Der Pathologe, v. 23, n. 5, p. 386–388, set. 2002.
MOTTA, A. C.; DUEK, E. A. R. Síntese, caracterização e degradação “in vitro” do poli( L-ácido láctico-co-ácido glicólico). Matéria (Rio de Janeiro), v. 11, n. 3, p. 340–350, set. 2006.
NAGRIK, S. M. et al. Advances in Transdermal Drug Delivery: The Development of Microneedle Technology for Improved Therapeutic Outcomes. Journal for Research in Applied Sciences and Biotechnology, v. 3, n. 5, p. 200–210, 14 nov. 2024.
NGUYEN, H. X. et al. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin. European Journal of Pharmaceutics and Biopharmaceutics, v. 129, p. 88–103, ago. 2018.
NGUYEN, H. X.; NGUYEN, C. N. Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals. Pharmaceutics, v. 15, n. 1, p. 277, 13 jan. 2023.
PAGE, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, p. n71, 29 mar. 2021.
PANDA, A. et al. Non-dermal applications of microneedle drug delivery systems. Drug Delivery and Translational Research, v. 12, n. 1, p. 67–78, jan. 2022.
PAULIGK, C. et al. The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (The QoLiTax-Trial of the Arbeitsgemeinschaft Internistische Onkologie, AIO). Journal of Clinical Oncology, v. 32, n. 15_suppl, p. 9621–9621, 20 maio 2014.
PERE, C. P. P. et al. 3D printed microneedles for insulin skin delivery. International Journal of Pharmaceutics, v. 544, n. 2, p. 425–432, jun. 2018.
REINKE, A. et al. The advantages of microneedle patches compared to conventional needle-based drug delivery and biopsy devices in medicine. Biomedical Engineering Advances, v. 8, p. 100127, nov. 2024.
RENOUF-GLAUSER, A. C. et al. A degradation study of PLLA containing lauric acid. Biomaterials, v. 26, n. 15, p. 2415–2422, maio 2005.
ROJEKAR, S. et al. Etravirine-loaded dissolving microneedle arrays for long-acting delivery. European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 41–51, ago. 2021.
ROY, G. et al. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis. International Journal of Pharmaceutics, v. 572, p. 118808, dez. 2019.
ROY, S. KR. et al. Microneedles: An Efficient Technique to Increase Transdermal Drug Delivery System. Current Drug Delivery, v. 21, 18 jul. 2024.
RUAN, S. et al. Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer’s disease treatment. Journal of Controlled Release, v. 366, p. 712–731, fev. 2024.
SABRI, A. H. et al. Intradermal and transdermal drug delivery using microneedles – Fabrication, performance evaluation and application to lymphatic delivery. Advanced Drug Delivery Reviews, v. 153, p. 195–215, jan. 2020a.
SABRI, A. H. et al. Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma. International Journal of Pharmaceutics, v. 589, p. 119808, nov. 2020b.
SAMIKSHA B. ROTAKE et al. Transdermal drug delivery system recent advancements: A comprehensive review. GSC Biological and Pharmaceutical Sciences, v. 28, n. 2, p. 059–072, 30 ago. 2024.
SEKAR, L. et al. Advancements in microneedle technology: comprehensive insights into versatile drug delivery mechanisms. International Journal of Applied Pharmaceutics, p. 1–11, 7 mar. 2024.
SHAMBLIN, S. L.; ZOGRAFI, G. The Effects of Absorbed Water on the Properties of Amorphous Mixtures Containing Sucrose. Pharmaceutical Research, v. 16, n. 7, p. 1119–1124, 1999.
SHARMA, S. et al. Rapid, low cost prototyping of transdermal devices for personal healthcare monitoring. Sensing and Bio-Sensing Research, v. 13, p. 104–108, abr. 2017.
SHEN, C.-C. et al. Modifying microphase separation of PVA based membranes for improving proton/methanol selectivity. Desalination, v. 233, n. 1–3, p. 82–87, dez. 2008.
SHOJI, A. et al. Assessing the Intestinal Permeability of Small Molecule Drugs via Diffusion Motion on a Multidimensional Free Energy Surface. Journal of Chemical Theory and Computation, v. 18, n. 1, p. 503–515, 11 jan. 2022.
SILVA, F. M. et al. Topically Applied Anti-Inflammatory Properties of Medicinal Plants: A Systematic Review. Amazônia Science and Health, v. 11, n. 4, 2023.
SINGARAJU, M. et al. Safety Profile and Toxicity Amelioration Strategies of Common Adverse Effects Associated with Anticancer Medications. Journal of Pharmaceutical Research International, p. 18–30, 6 jul. 2020.
SINGH, H. et al. Encapsulating Rifampicin into SLNs: A Viable Option for Managing its Bioavailability Issues Upon Co-Delivery with Isoniazid. Current Drug Delivery, v. 17, n. 4, p. 343–347, 27 jun. 2020.
SIVADASAN, D.; MADKHALI, O. A. The Design Features, Quality by Design Approach, Characterization, Therapeutic Applications, and Clinical Considerations of Transdermal Drug Delivery Systems—A Comprehensive Review. Pharmaceuticals, v. 17, n. 10, p. 1346, 9 out. 2024.
STARLIN CHELLATHURAI, M. et al. Biodegradable polymeric insulin microneedles – a design and materials perspective review. Drug Delivery, v. 31, n. 1, p. 2296350, 31 dez. 2024.
TUAN-MAHMOOD, T.-M. et al. Microneedles for intradermal and transdermal drug delivery. European Journal of Pharmaceutical Sciences, v. 50, n. 5, p. 623–637, dez. 2013.
VEDIKA N. DAFE et al. Transdermal insulin delivery via microneedle technology, patches, and pumps offers a promising alternative to traditional subcutaneous injections for diabetes management. GSC Biological and Pharmaceutical Sciences, v. 29, n. 1, p. 233–242, 30 out. 2024.
VOLPE-ZANUTTO, F. et al. Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii. Journal of Controlled Release, v. 333, p. 298–315, maio 2021.
VORA, L. K. et al. Long-acting microneedle formulations. Advanced Drug Delivery Reviews, v. 201, p. 115055, out. 2023.
WAGHULE, T. et al. Microneedles: A smart approach and increasing potential for transdermal drug delivery system. Biomedicine & Pharmacotherapy, v. 109, p. 1249–1258, jan. 2019.
WANG, B. et al. Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation. Asian Journal of Pharmaceutical Sciences, v. 18, n. 1, p. 100776, jan. 2023.
WEI, Q. et al. Skin permeable polymer for noninvasive transdermal insulin delivery. Bioengineering, , 8 maio 2023. Disponível em: <http://biorxiv.org/lookup/doi/10.1101/2023.05.05.539551>. Acesso em: 4 jan. 2025
WEN, P. et al. Liposome-loaded dissolvable microneedle patches for more efficient intradermal antigen delivery of Hepatitis B vaccine. International Journal of Pharmaceutics, v. 669, p. 125023, 25 jan. 2025.
WENNBERG, C. et al. Understanding Drug Skin Permeation Enhancers Using Molecular Dynamics Simulations. Journal of Chemical Information and Modeling, v. 63, n. 15, p. 4900–4911, 14 ago. 2023.
YANG, Y. et al. Preparation of biodegradable poly(lactic acid)/poly[(butylene diglycolate)‐ CO ‐furandicarboxylate] blends with excellent toughness and gas barrier performance. Polymer International, p. pi.6692, 27 ago. 2024.
YUAN, Y. et al. Prediction of drug permeation through microneedled skin by machine learning. Bioengineering & Translational Medicine, v. 8, n. 6, p. e10512, nov. 2023.
ZHANG, P.; ZHANG, Y.; LIU, C.-G. Polymeric nanoparticles based on carboxymethyl chitosan in combination with painless microneedle therapy systems for enhancing transdermal insulin delivery. RSC Advances, v. 10, n. 41, p. 24319–24329, 2020.
ZHANG, Y. et al. Microneedles fabricated from alginate and maltose for transdermal delivery of insulin on diabetic rats. Materials Science and Engineering: C, v. 85, p. 18–26, abr. 2018.
ZHANG, Z. et al. Viscoelastic Properties of Polymeric Microneedles Determined by Micromanipulation Measurements and Mathematical Modelling. Materials, v. 16, n. 5, p. 1769, 21 fev. 2023.
ZHAO, L. et al. Implantable Microarray Patch: Engineering at the Nano and Macro Scale for Sustained Therapeutic Release via Synthetic Biodegradable Polymers. Advanced Materials Technologies, p. 2400346, 23 out. 2024.
